Sympathetic Neural Patterns and Transduction in Obesity-associated Hypertension

Who is this study for? Adult patients with obesity and hypertension
What treatments are being studied? Neuropeptide Y
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: t
View:

• Control - BMI\<30, age 18-55

• Hypertensive - BMI\<30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring Obese- BMI\>30, age 18-55 Obese-hypertensive- BMI\>30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring

Locations
United States
Texas
University of Texas Southwestern Medical Center
RECRUITING
Dallas
Contact Information
Primary
Christopher M Hearon, Ph.D.
christopher.hearon@utsouthwestern.edu
214-345-4624
Backup
Mary Childers
marychilders@texashealth.org
214-345-6459
Time Frame
Start Date: 2021-07-18
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 100
Treatments
Experimental: Healthy Control
Healthy age matched controls with no history of cardiovascular disease and normal bodyweight
Experimental: Hypertensive
Hypertensive adults who are not obese
Experimental: Obese
Obese adults who are not hypertensive
Experimental: Obese-hypertensive
Obese adults who are being treated for hypertension
Sponsors
Leads: University of Texas Southwestern Medical Center

This content was sourced from clinicaltrials.gov